Drugs / ARALAST Fr. IV-1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00242385 | Dec 2005 → Jun 2006 | alpha 1-antitrypsin deficiency | Baxalta now part of Shire | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ARALAST Fr. IV-1 | “ARALAST Fraction IV-1 Alpha1-Proteinase Inhibitor (ARALAST Fr. IV-1)” NCT00242385 ↗ |
| Modality | Protein / enzyme biologic | “functionally intact human Alpha1- Proteinase Inhibitor (α1-PI)” NCT00242385 ↗ |